Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Schembl19680724
2. Gtpl11202
3. Gb-1211
4. Compound 11d [zetterberg Et Al., 2022]
5. 2-(5-bromopyridin-3-yl)sulfanyl-6-(hydroxymethyl)-4-[4-(3,4,5-trifluorophenyl)triazol-1-yl]oxane-3,5-diol
| Molecular Weight | 533.3 g/mol |
|---|---|
| Molecular Formula | C19H16BrF3N4O4S |
| XLogP3 | 1.9 |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 5 |
| Exact Mass | 532.00277 g/mol |
| Monoisotopic Mass | 532.00277 g/mol |
| Topological Polar Surface Area | 139 Ų |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 625 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 5 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A GB1211 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of GB1211, including repackagers and relabelers. The FDA regulates GB1211 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. GB1211 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A GB1211 supplier is an individual or a company that provides GB1211 active pharmaceutical ingredient (API) or GB1211 finished formulations upon request. The GB1211 suppliers may include GB1211 API manufacturers, exporters, distributors and traders.
GB1211 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of GB1211 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right GB1211 GMP manufacturer or GB1211 GMP API supplier for your needs.
A GB1211 CoA (Certificate of Analysis) is a formal document that attests to GB1211's compliance with GB1211 specifications and serves as a tool for batch-level quality control.
GB1211 CoA mostly includes findings from lab analyses of a specific batch. For each GB1211 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
GB1211 may be tested according to a variety of international standards, such as European Pharmacopoeia (GB1211 EP), GB1211 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (GB1211 USP).
LOOKING FOR A SUPPLIER?
